Carlyle's J&J Carveout Stinging Creditors as Earnings Plummet

Lenders who funded Carlyle Group LP’s $4 billion buyout of Johnson & Johnson’s medical diagnostics division 18 months ago are feeling the pain from the company’s sinking earnings.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.